Navigation Links
Apieron Secures Series D Commitments

MENLO PARK, Calif., June 1 /PRNewswire/ -- In its Series D round of fundraising, Apieron Inc. said that it closed on commitments from all of its previous venture investors. The round presently includes Alliance Technology Ventures, Canaan Partners, Draper Fisher Jervetson and Onset Ventures.

"With commitments from our previous venture investors, we are more than well on our way to securing our financing target and closing the round," said Holly McGarraugh, Apieron President and CEO. "The ongoing support of our past investors is a significant vote of confidence in our plan to improve the treatment of asthma with the simple, accurate, safe and efficient measurement of exhaled nitric oxide, a well-documented marker for airway inflammation."

Apieron is a medical device company dedicated to developing innovative solutions to improve the standard of care for people with asthma. Its Insight(TM) eNO System measures exhaled nitric oxide (eNO) which is a well established indicator of airway inflammation for asthma management. Utilizing a proprietary biosensor, Apieron's Insight eNO System can detect trace amounts of nitric oxide in a patient's breath. It is highly accurate, non-invasive, safe, easy to use, and provides results in less than a minute. Current methods and techniques used to manage and treat asthma are costly, time-consuming and cumbersome.

A much awaited breakthrough in medical technology, and designed for the physician's office, the Insight eNO System is a practical and affordable device for inflammatory airway measurement in asthma. The measurement of eNO has also been shown to optimize medication therapy and improve compliance among patients with asthma.

Since closing its C round in 2007, Apieron received FDA clearance for its Insight eNO System in March 2008 and began selling to physicians offices in the United States. Apieron has also secured FDA clearance for a multi-use sensor, which improves clinical practice flow by providing up to 10 tests on a single sensor, virtually eliminating the warm-up time between patient tests. The funds in the Series D round are to be used for market growth and additional product development.

It is estimated that more than 26 million people in the U.S. suffer from asthma, making it one of the most common and costly of all diseases. In fact, every day in America 40,000 people miss school or work due to asthma and 5,000 people go to the emergency room due to an asthma attack. One-quarter of all emergency room visits are asthma related and asthma is the most common chronic childhood disease.

About the Insight eNO System

The Insight eNO System has been available for use in the physician's office since March 2008. The system uses a proprietary biosensor technology to measure exhaled nitric oxide, a well established indicator of asthma severity and steroid responsive airway inflammation. Measuring eNO and determining the level of airway inflammation can help clinicians more closely manage their patients' inflammatory condition and therefore more precisely titrate medications, which can lead to fewer asthma exacerbations.

About Apieron Inc.

Apieron Inc. is a private, venture-backed medical device company based in Menlo Park, CA that was formed in early 2001 to develop a simple-to-use, non-invasive monitor for the measurement of exhaled nitric oxide (eNO) for the management of asthma. The Apieron biosensor technology platform utilizes a patented technology that allows for the highly sensitive detection of selected analytes like eNO. Apieron is committed to collaborating with physicians and patients to develop innovative medical solutions to improve quality of life and standards of care.

SOURCE Apieron Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Apieron Strengthens Senior Leadership With Commercial, Financial Appointments
2. Sonitus Medical Secures Strategic Investment and Technology Advancement Agreement From In-Q-Tel
3. MedAptus Secures $6 Million Investment
4. Still River Systems, Inc. Secures $33 Million in Private Financing
5. Solta Medical, Inc. Secures $9M Credit Facility from Silicon Valley Bank
6. Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets
7. Noteworthy Medical Systems, Inc. Secures Capital from Top European eHealth Provider and Closes on Merger with Strategic Partner
8. Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox Industries
9. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus
10. Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO
11. Stuart M. Goldstein, Southern New Jersey Patent and Intellectual Property Attorney, secures a New Revolutionary Eco-Friendly Patent
Post Your Comments:
(Date:11/24/2015)... , ... November 24, 2015 , ... ... the organization will waive paid entry and parking fees at several of their ... Monument Mountain in Great Barrington in support of REI’s Black Friday #OptOutside Campaign. ...
(Date:11/24/2015)... ... November 24, 2015 , ... Cancer patients, survivors, caregivers, ... at a live taping of the next CURE Connections® video series ... Cancers 2015 Symposium at Georgetown University Hotel & Conference Center in Washington, D.C. ...
(Date:11/24/2015)... ... 2015 , ... With Thanksgiving right around the corner, holiday travel season is ... your family and vehicle. , According to the National Highway Traffic Safety Administration, 301 ... sharing the following safety tips from the NHTSA: , ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Cleveland University-Kansas City (CU-KC), in Overland Park, Kansas. Benson, a fifth-trimester ... University President Carl S. Cleveland III on October 16. , “Katie is very ...
(Date:11/24/2015)... ... 24, 2015 , ... Bibliomotion is thrilled to announce the launch ... and Diversity by Nancy M. Schlichting, Chief Executive Officer of Henry Ford ... address the needs of patients and their families, shaped my desire to improve the ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Avery Biomedical Devices (ABD), manufacturer of the ... appointment of Anders Jonzon , MD; Ph.D. as ... Dr. Jonzon is a Physiologist and consultant ... University, Uppsala and Children,s Hospital, Karolinska, Stockholm, ... at the Cardiovascular Institute (UCSF). His research has covered ...
(Date:11/24/2015)... BERN, Switzerland , November 24, 2015 ... Engineering Research of the University of Bern ... and Clinical Nutrition of the Bern University Hospital "Inselspital" ... collaboration to develop a novel generation artificial pancreas. Combining ... of insulin for diabetic patients with the unequalled accuracy ...
(Date:11/24/2015)... 24, 2015 Diplomat Pharmacy, Inc. (NYSE: DPLO) announced ... Clinical Services, Education and Human Resources will be presenting in ... Drugs: Health Plan Strategies for a Dynamic Market" on Dec. ... , a consultant with the Cambridge Advisory Group, where she ... The webinar will discuss the rapid growth of ...
Breaking Medicine Technology: